APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical and Biopharmaceutical Safety Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Analysis and Forecast 2026-2032

12 August 2026194 pages

Choose your research edition.

Industry ResearchPharmaceutical and Biopharmaceutical Safety Testing Service Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pharmaceutical and Biopharmaceutical Safety Testing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharmaceutical and Biopharmaceutical Safety Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmaceutical and Biopharmaceutical Safety Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmaceutical and Biopharmaceutical Safety Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmaceutical and Biopharmaceutical Safety Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharmaceutical and Biopharmaceutical Safety Testing Service include Eurofins Scientific, SGS, Q2 Solutions, Samsung Biologics, Texcell, WuXi Biologics, Wuhan Canvest Biotechnology, Centre Testing International (CTI) and Suzhou Liangchen Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharmaceutical and Biopharmaceutical Safety Testing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmaceutical and Biopharmaceutical Safety Testing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical and Biopharmaceutical Safety Testing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical and Biopharmaceutical Safety Testing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical and Biopharmaceutical Safety Testing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical and Biopharmaceutical Safety Testing Service revenue, projected growth trends, production technology, application and end-user industry.

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Company

Eurofins Scientific

SGS

Q2 Solutions

Samsung Biologics

Texcell

WuXi Biologics

Wuhan Canvest Biotechnology

Centre Testing International (CTI)

Suzhou Liangchen Biotechnology

JADE Biomedical

Standard Testing Group

Sino Tech World Biologicals

CAS Testing Technical Services

NTEK

Sino Biological

Miracle Points

Suzhou Cefety Bioscience

Zhejiang Hengyu Biological

Merck

Charles River Laboratories

Sartorius

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Type

Raw Materials

Viral Banks

Cell Banks

Others

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Application

Pharmaceutical and Biotechnology Companies

CROs and CDMOs

Academic and Research Institutions

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical and Biopharmaceutical Safety Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical and Biopharmaceutical Safety Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical and Biopharmaceutical Safety Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharmaceutical and Biopharmaceutical Safety Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharmaceutical and Biopharmaceutical Safety Testing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical and Biopharmaceutical Safety Testing Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Raw Materials Major Player Table 3. Viral Banks Major Player Table 4. Cell Banks Major Player Table 5. Others Major Player Table 6. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical and Biotechnology Companies Major Player Table 8. CROs and CDMOs Major Player Table 9. Academic and Research Institutions Major Player Table 10. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Trends Table 11. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Drivers Table 12. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Opportunities and Challenges Table 13. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Restraints Table 14. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Region (2021-2026) Table 17. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Region (2027-2032) Table 19. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Players (2021-2026) Table 21. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Key Players Headquarters & Area Served Table 23. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Players, Product Type & Application Table 24. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Pharmaceutical and Biopharmaceutical Safety Testing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Type (2021-2026) Table 31. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Type (2027-2032) Table 32. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Application (2021-2026) Table 36. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Application (2027-2032) Table 37. Eurofins Scientific Company Information Table 38. Eurofins Scientific Business Overview Table 39. Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 41. Eurofins Scientific Recent Development Table 42. SGS Company Information Table 43. SGS Business Overview Table 44. SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 46. SGS Recent Development Table 47. Q2 Solutions Company Information Table 48. Q2 Solutions Business Overview Table 49. Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 51. Q2 Solutions Recent Development Table 52. Samsung Biologics Company Information Table 53. Samsung Biologics Business Overview Table 54. Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 56. Samsung Biologics Recent Development Table 57. Texcell Company Information Table 58. Texcell Business Overview Table 59. Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 61. Texcell Recent Development Table 62. WuXi Biologics Company Information Table 63. WuXi Biologics Business Overview Table 64. WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 66. WuXi Biologics Recent Development Table 67. Wuhan Canvest Biotechnology Company Information Table 68. Wuhan Canvest Biotechnology Business Overview Table 69. Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 71. Wuhan Canvest Biotechnology Recent Development Table 72. Centre Testing International (CTI) Company Information Table 73. Centre Testing International (CTI) Business Overview Table 74. Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 76. Centre Testing International (CTI) Recent Development Table 77. Suzhou Liangchen Biotechnology Company Information Table 78. Suzhou Liangchen Biotechnology Business Overview Table 79. Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 81. Suzhou Liangchen Biotechnology Recent Development Table 82. JADE Biomedical Company Information Table 83. JADE Biomedical Business Overview Table 84. JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 86. JADE Biomedical Recent Development Table 87. Standard Testing Group Company Information Table 88. Standard Testing Group Business Overview Table 89. Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 91. Standard Testing Group Recent Development Table 92. Sino Tech World Biologicals Company Information Table 93. Sino Tech World Biologicals Business Overview Table 94. Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 96. Sino Tech World Biologicals Recent Development Table 97. CAS Testing Technical Services Company Information Table 98. CAS Testing Technical Services Business Overview Table 99. CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 101. CAS Testing Technical Services Recent Development Table 102. NTEK Company Information Table 103. NTEK Business Overview Table 104. NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 106. NTEK Recent Development Table 107. Sino Biological Company Information Table 108. Sino Biological Business Overview Table 109. Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 111. Sino Biological Recent Development Table 112. Miracle Points Company Information Table 113. Miracle Points Business Overview Table 114. Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 116. Miracle Points Recent Development Table 117. Suzhou Cefety Bioscience Company Information Table 118. Suzhou Cefety Bioscience Business Overview Table 119. Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 121. Suzhou Cefety Bioscience Recent Development Table 122. Zhejiang Hengyu Biological Company Information Table 123. Zhejiang Hengyu Biological Business Overview Table 124. Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 126. Zhejiang Hengyu Biological Recent Development Table 127. Merck Company Information Table 128. Merck Business Overview Table 129. Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 131. Merck Recent Development Table 132. Charles River Laboratories Company Information Table 133. Charles River Laboratories Business Overview Table 134. Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 136. Charles River Laboratories Recent Development Table 137. Sartorius Company Information Table 138. Sartorius Business Overview Table 139. Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 141. Sartorius Recent Development Table 142. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 143. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 144. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 145. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 146. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 148. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 149. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 150. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 151. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 155. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 156. China Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 157. China Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 158. China Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 159. China Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 161. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 162. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Region (US$ Million) & (2021-2026) Table 166. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Region (US$ Million) & (2027-2032) Table 167. SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 168. SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 169. SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 173. SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Pharmaceutical and Biopharmaceutical Safety Testing Service Image Figure 2. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Raw Materials Image Figure 5. Viral Banks Image Figure 6. Cell Banks Image Figure 7. Others Image Figure 8. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical and Biotechnology Companies Image Figure 11. CROs and CDMOs Image Figure 12. Academic and Research Institutions Image Figure 13. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (US$ Million) & (2021-2032) Figure 14. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Type (2021-2032) Figure 21. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Application (2021-2032) Figure 24. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Type (2021-2032) Figure 26. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Application (2021-2032) Figure 27. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Country (2021-2032) Figure 28. United States Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Type (2021-2032) Figure 33. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Application (2021-2032) Figure 34. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Country (2021-2032) Figure 35. Germany Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Type (2021-2032) Figure 45. China Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Application (2021-2032) Figure 46. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Type (2021-2032) Figure 48. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Application (2021-2032) Figure 49. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Region (2021-2032) Figure 50. Japan Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Type (2021-2032) Figure 58. SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Application (2021-2032) Figure 59. SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Country (2021-2032) Figure 60. Brazil Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Raw Materials
  • Viral Banks
  • Cell Banks
  • Others
Applications
  • Pharmaceutical and Biotechnology Companies
  • CROs and CDMOs
  • Academic and Research Institutions
Companies covered
  • Eurofins Scientific
  • SGS
  • Q2 Solutions
  • Samsung Biologics
  • Texcell
  • WuXi Biologics
  • Wuhan Canvest Biotechnology
  • Centre Testing International (CTI)
  • Suzhou Liangchen Biotechnology
  • JADE Biomedical
  • Standard Testing Group
  • Sino Tech World Biologicals
  • CAS Testing Technical Services
  • NTEK
  • Sino Biological
  • Miracle Points
  • Suzhou Cefety Bioscience
  • Zhejiang Hengyu Biological
  • Merck
  • Charles River Laboratories
  • Sartorius

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Type
  3. 1.2.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Raw Materials
  5. 1.2.3 Viral Banks
  6. 1.2.4 Cell Banks
  7. 1.2.5 Others
  8. 1.3 Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Application
  9. 1.3.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical and Biotechnology Companies
  11. 1.3.3 CROs and CDMOs
  12. 1.3.4 Academic and Research Institutions
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Dynamics
  1. 2.1 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Trends
  2. 2.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Drivers
  3. 2.3 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Perspective (2021-2032)
  2. 3.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Growth Trends by Region
  3. 3.2.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Players
  2. 4.1.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Key Players Headquarters & Area Served
  7. 4.4 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Players, Product Type & Application
  8. 4.5 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market CR5 and HHI
  11. 4.6.3 2025 Pharmaceutical and Biopharmaceutical Safety Testing Service Tier 1, Tier 2, and Tier 3
5 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type
  1. 5.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2032)
  3. 5.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Type (2021-2032)
6 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application
  1. 6.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2032)
  3. 6.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eurofins Scientific
  2. 7.1.1 Eurofins Scientific Company Information
  3. 7.1.2 Eurofins Scientific Business Overview
  4. 7.1.3 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  6. 7.1.5 Eurofins Scientific Recent Developments
  7. 7.2 SGS
  8. 7.2.1 SGS Company Information
  9. 7.2.2 SGS Business Overview
  10. 7.2.3 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  12. 7.2.5 SGS Recent Developments
  13. 7.3 Q2 Solutions
  14. 7.3.1 Q2 Solutions Company Information
  15. 7.3.2 Q2 Solutions Business Overview
  16. 7.3.3 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  18. 7.3.5 Q2 Solutions Recent Developments
  19. 7.4 Samsung Biologics
  20. 7.4.1 Samsung Biologics Company Information
  21. 7.4.2 Samsung Biologics Business Overview
  22. 7.4.3 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  24. 7.4.5 Samsung Biologics Recent Developments
  25. 7.5 Texcell
  26. 7.5.1 Texcell Company Information
  27. 7.5.2 Texcell Business Overview
  28. 7.5.3 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  30. 7.5.5 Texcell Recent Developments
  31. 7.6 WuXi Biologics
  32. 7.6.1 WuXi Biologics Company Information
  33. 7.6.2 WuXi Biologics Business Overview
  34. 7.6.3 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  36. 7.6.5 WuXi Biologics Recent Developments
  37. 7.7 Wuhan Canvest Biotechnology
  38. 7.7.1 Wuhan Canvest Biotechnology Company Information
  39. 7.7.2 Wuhan Canvest Biotechnology Business Overview
  40. 7.7.3 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  42. 7.7.5 Wuhan Canvest Biotechnology Recent Developments
  43. 7.8 Centre Testing International (CTI)
  44. 7.8.1 Centre Testing International (CTI) Company Information
  45. 7.8.2 Centre Testing International (CTI) Business Overview
  46. 7.8.3 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  48. 7.8.5 Centre Testing International (CTI) Recent Developments
  49. 7.9 Suzhou Liangchen Biotechnology
  50. 7.9.1 Suzhou Liangchen Biotechnology Company Information
  51. 7.9.2 Suzhou Liangchen Biotechnology Business Overview
  52. 7.9.3 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  54. 7.9.5 Suzhou Liangchen Biotechnology Recent Developments
  55. 7.10 JADE Biomedical
  56. 7.10.1 JADE Biomedical Company Information
  57. 7.10.2 JADE Biomedical Business Overview
  58. 7.10.3 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  60. 7.10.5 JADE Biomedical Recent Developments
  61. 7.11 Standard Testing Group
  62. 7.11.1 Standard Testing Group Company Information
  63. 7.11.2 Standard Testing Group Business Overview
  64. 7.11.3 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  66. 7.11.5 Standard Testing Group Recent Developments
  67. 7.12 Sino Tech World Biologicals
  68. 7.12.1 Sino Tech World Biologicals Company Information
  69. 7.12.2 Sino Tech World Biologicals Business Overview
  70. 7.12.3 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  72. 7.12.5 Sino Tech World Biologicals Recent Developments
  73. 7.13 CAS Testing Technical Services
  74. 7.13.1 CAS Testing Technical Services Company Information
  75. 7.13.2 CAS Testing Technical Services Business Overview
  76. 7.13.3 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  78. 7.13.5 CAS Testing Technical Services Recent Developments
  79. 7.14 NTEK
  80. 7.14.1 NTEK Company Information
  81. 7.14.2 NTEK Business Overview
  82. 7.14.3 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  84. 7.14.5 NTEK Recent Developments
  85. 7.15 Sino Biological
  86. 7.15.1 Sino Biological Company Information
  87. 7.15.2 Sino Biological Business Overview
  88. 7.15.3 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  90. 7.15.5 Sino Biological Recent Developments
  91. 7.16 Miracle Points
  92. 7.16.1 Miracle Points Company Information
  93. 7.16.2 Miracle Points Business Overview
  94. 7.16.3 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  96. 7.16.5 Miracle Points Recent Developments
  97. 7.17 Suzhou Cefety Bioscience
  98. 7.17.1 Suzhou Cefety Bioscience Company Information
  99. 7.17.2 Suzhou Cefety Bioscience Business Overview
  100. 7.17.3 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  102. 7.17.5 Suzhou Cefety Bioscience Recent Developments
  103. 7.18 Zhejiang Hengyu Biological
  104. 7.18.1 Zhejiang Hengyu Biological Company Information
  105. 7.18.2 Zhejiang Hengyu Biological Business Overview
  106. 7.18.3 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  108. 7.18.5 Zhejiang Hengyu Biological Recent Developments
  109. 7.19 Merck
  110. 7.19.1 Merck Company Information
  111. 7.19.2 Merck Business Overview
  112. 7.19.3 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  114. 7.19.5 Merck Recent Developments
  115. 7.20 Charles River Laboratories
  116. 7.20.1 Charles River Laboratories Company Information
  117. 7.20.2 Charles River Laboratories Business Overview
  118. 7.20.3 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  120. 7.20.5 Charles River Laboratories Recent Developments
  121. 7.21 Sartorius
  122. 7.21.1 Sartorius Company Information
  123. 7.21.2 Sartorius Business Overview
  124. 7.21.3 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  126. 7.21.5 Sartorius Recent Developments
8 North America
  1. 8.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (2021-2032)
  2. 8.2 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2027-2032)
  5. 8.3 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2027-2032)
  9. 8.5 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country
  11. 8.6.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (2021-2032)
  2. 9.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2027-2032)
  5. 9.3 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2027-2032)
  9. 9.5 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country
  11. 9.6.1 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (2021-2032)
  2. 10.2 China Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2032)
  3. 10.2.1 China Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2026)
  4. 10.2.2 China Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2027-2032)
  5. 10.3 China Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Type (2021-2032)
  6. 10.4 China Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2032)
  7. 10.4.1 China Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2026)
  8. 10.4.2 China Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2027-2032)
  9. 10.5 China Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (2021-2032)
  2. 11.2 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2027-2032)
  5. 11.3 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2027-2032)
  9. 11.5 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country
  11. 11.6.1 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (2021-2032)
  2. 12.2 SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country
  11. 12.6.1 SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst